USE OF A COLOR TO IMPROVE SIGNAL DETECTION IN A METHOD OF ANALYSIS

专利摘要:
The present invention relates to the use of at least one dye for improving the detection of a signal corresponding to the presence of an analyte in a spot analysis method (s), in particular when the detection of the signal occurs in the presence of a liquid phase. The present invention also relates to a spot analysis method (s) for improving the detection of a signal corresponding to the presence of an analyte, in the presence of a liquid phase comprising at least one dye.
公开号:FR3019899A1
申请号:FR1453168
申请日:2014-04-09
公开日:2015-10-16
发明作者:Bertrand Merandon；Christophe Vedrine
申请人:Bio Rad Innovations SAS；
IPC主号:

专利说明:

[0001] TECHNICAL FIELD The present invention relates to the improvement of the detection of a signal corresponding to the presence of an analyte during an analysis process. in particular when the analysis method requires acquisition of the signal in the presence of a liquid phase.
[0002] STATE OF THE ART An analysis method makes it possible to detect the possible presence of one or more analytes in a sample. An analysis method is generally carried out on a solid support. Among the analysis methods, the multiplex analysis method makes it possible to detect, simultaneously, the possible presence of several analytes within the same sample. A multiplex analysis method can be carried out on a solid support comprising spots or a set of balls. Conventionally, a method of analysis comprises a step of bringing a sample to be analyzed into contact with at least one spot of a solid support or beads comprising a capture ligand specific for an analyte to be detected, a step of adding an analyte-specific detection ligand to detect and coupled to a direct or indirect marker, a possible revelation step by adding a reporter itself coupled to a direct or indirect marker, and a detection step signal (also called signal acquisition step). In the case of an indirect marker of the peroxidase enzyme type, the addition of a substrate of the enzyme allows an enzymatic reaction which leads to the production of a chemiluminescent compound. The signal is then detected in chemiluminescence. The detection of a signal in chemiluminescence requires, in principle, to achieve the acquisition of the signal in the presence of the substrate of the enzyme, that is to say in the presence of a liquid phase, to allow the production of the chemiluminescent compound continuously. Indeed, if a washing step is performed before the acquisition of the signal, the residual substrate is removed and the enzymatic reaction stops. Now, the signal emitted by the chemiluminescent compound gradually goes out. Accordingly, the enzyme substrate must be present in a liquid phase in contact with the solid phase to allow a sufficiently stable and reproducible signal emission.
[0003] However, the acquisition of a signal at the spots of a well of a microplate in the presence of a liquid phase leads to light interference.
[0004] These light interferences have several origins: on the one hand, photons emitted from the spots towards the top of the well can interact with the compounds of the solution comprising the chemiluminescent compound and be diffused in all directions; on the other hand, the photons can also be reflected by the walls of the well and by the change of medium at the level of the liquid / air interface, more precisely at the level of the meniscus formed by the interaction of the wall of the well and the the solution comprising the chemiluminescent compound. These light interferences can produce spots called "twin spots", slightly offset from the actual spots, a visible light ring at the periphery of the well, or a bright arc when the signal emitted at a spot is strong. These light interferences thus induce a problematic background noise, which can be at the origin of false negative results or false positive results. For example, the light ring around the well can skew the threshold of the background noise, a weak signal then being embedded in the background noise. The light interferences can also hinder the verification of the absence of a defect of a spot made by an annular measurement around a spot. EP 0 165 072 discloses the use of an attenuator, preferably a mixture of red and yellow dyes, for suppressing undesirable light and false positive results in a process involving luminescent light emission. In this document, undesirable light is adjacent to the measured surfaces. The test is performed in a hollow elongated pipette comprising a plurality of cotton threads, each cotton thread being bonded to a single type of antigen. The pipette is closed with a transparent window. The signal is revealed in the dark by squeezing a film on the surface of the pipette. The attenuator makes it possible to eliminate the false positive results linked to the non-specific binding of the HRP peroxidase enzyme to the cotton threads. US 8 163 562 discloses a test for reducing the undesirable light resulting from the fluorescence of a solution in which a cell compartment is bathed which is preferably a cell. This undesirable fluorescence comes in particular probes or chemical compounds used during the test. The signal to be detected comes from a photon generating agent located in the membrane compartment. For this purpose, a membrane-impermeable photon reducing agent which does not specifically bind to the membrane is used in the aqueous solution in contact with the outer surface of the membrane compartment. The photon reducing agent may be a dye or a mixture of dyes.
[0005] There is therefore a need for solutions to improve the detection of a signal corresponding to the presence of an analyte in the context of a spot analysis method (s) in which the acquisition of the signal at the level of spot or spots occurs in the presence of a liquid phase, to secure the results obtained by avoiding false positive or false negative results. DETAILED DESCRIPTION In a spot analysis method (s), the inventors have shown that the use of a dye, for example tartrazine, makes it possible to eliminate, partially or totally, the undesirable light interferences which ordinarily occur when acquiring a signal in the presence of a liquid phase, without, however, interfering or interfering with the intensity of the detected signal corresponding to the presence of an analyte at a spot (by example in luminescence and / or fluorescence), or with the possible detection of the fluorescence emitted by a fluorophore present as a control at the spot or spots. The use of a dye according to the invention thus makes it possible to secure the results obtained at the end of an analysis process, that is to say to guarantee the reliability of said results obtained at the end of said process. , in particular by avoiding making false-positive (also called false-positive) and / or false-negative (also known as false-negative) results. A "false positive" is a positive result reflecting the presence of one or more analytes to be detected in a sample, while said one or more analytes were present in the sample and therefore should not have been detected. A "false negative" is a negative result reflecting the absence of one or more analytes to be detected in a sample, while said one or more analytes were present in the sample and should have been detected. The detected signal corresponding to the presence of an analyte at a spot makes it possible to detect the presence of an analyte in a sample and / or to quantify said analyte in said sample.
[0006] The detected signal corresponding to the presence of an analyte at a spot is electromagnetic radiation, in particular light emission. The detected signal corresponding to the presence of an analyte at a spot is preferably a signal detected in luminescence, for example in chemiluminescence, and / or a signal detected in fluorescence.
[0007] The fluorophore present in the spot or spots of a solid support can serve, inter alia, to control the quality of the spot (s) (in particular their presence, location and / or integrity) at the end of an analysis process. and / or to improve the sensitivity of the detection of the analyte (s) by defining a reading grid of the signal corresponding to the analyte (s) from the actual location of the spot (s) at the end of the analysis method. The use of a fluorophore in the spot or spots of a solid support also makes it possible to secure the results of a spot analysis method (s). The use of a dye according to the invention thus makes it possible to improve (and thus secure) the detection of a signal corresponding to the presence of an analyte during an analysis process, by masking and / or absorbing, partially or totally, unwanted light interference when acquiring a signal to be detected in the presence of a liquid phase. The improvement of the signal detection can be evaluated by a measurement of the ratio "signal detected on background noise". Furthermore, the use of a dye in an analysis method according to the invention has the advantage of being able to use a solid support whose or walls of the compartment or compartments comprise or consist of a transparent material, which type of support being less expensive than those comprising or consisting of an opaque material. A first object of the invention is thus to provide a method of analysis, preferably a multiplex analysis method, for improving the detection of a signal corresponding to the presence of an analyte comprising the following steps: ) providing a solid support comprising at least one compartment, said compartment comprising at least one spot for the detection of an analyte, b) placing a sample to be analyzed in the presence of the spot or spots of said compartment of the solid support, c) implementing the presence of the spot or spots of said compartment at least one analyte detection ligand, said analyte detection ligand being coupled to a direct or indirect detection marker, d) when said detection marker is an indirect marker, put in the presence of the spot or spots of said compartment a reporter of the indirect detection marker coupled to said detection ligand, e) when the reporter used in step d) is coupled to a marker indirectly, bringing into the presence of the spot or spots of said compartment a reporter of the indirect detection marker coupled to said reporter, f) putting at least one dye in the presence of the spot or spots of said compartment, said one or more dyes being included in a liquid phase in contacting the spot or spots of said compartment, and g) detecting a signal corresponding to the presence of an analyte at the spot or spots of said compartment, in the presence of the liquid phase comprising said one or more dyes. A second subject of the invention relates to the use of at least one dye for improving the detection of a signal corresponding to the presence of an analyte in a spot analysis method (s), the improvement of the detection of the signal being for example characterized by a decrease in the intensity of the background noise. Sample The sample to be analyzed is preferably a biological sample.
[0008] The biological sample may be a biological fluid, such as a blood sample, derived from blood (such as plasma or serum), urine, cerebrospinal fluid, saliva, or a tissue sample, such as tissue obtained by biopsy , a cell a set of cells, a plant extract, or their combinations. A blood derivative refers to any product, in particular fluid, obtained from a blood sample. The sample to be analyzed may also be a culture medium and / or a culture supernatant. Before being analyzed, the sample may undergo one or more preliminary treatment steps, such as dilution, centrifugation, heat treatment, cell lysis (for example by one or more chaotropic agents, one or more reducing agents and / or by heating ), extraction, PCR (Polymerase Chain Reaction) reaction, addition of unlabeled detection ligand or combinations thereof. The addition of an unlabeled detection ligand is particularly useful for the implementation of a neutralization test, which is in itself a test known to those skilled in the art.
[0009] The sample may also be a mixture of at least two samples that may be of the same kind or of a different nature. By way of example of a mixture of samples of a different nature, mention may be made of a mixture of blood and serum, a mixture of blood and plasma, a mixture of serum and plasma, or a mixture of blood, serum and plasma.
[0010] A preferred sample according to the invention is a sample or a mixture of blood and / or blood-derived samples.
[0011] Analvte An analyte to be detected in the sample can be any type of compound, natural or synthetic, that it is desired to detect and / or quantify in a sample. An analyte may for example be a protein, a peptide, a glycoprotein, a carbohydrate, a lipid, a cell, an organelle, a virus or a nucleic acid. The cell may be an animal cell, a plant cell, a bacterial cell, a metazoan cell, a yeast cell, a mushroom cell or a protozoan. A nucleic acid denotes a polymer of nucleotides connected by phosphodiester bonds, such as a deoxyribonucleic acid (DNA), a ribonucleic acid (RNA) or an analogue thereof, such as phosphorothioates or thioesters, in single-stranded form or double strand. An analyte or at least one analyte is for example selected from the group consisting of an antigen, an antibody, an antibody fragment, a hapten, a hormone, a hormone receptor, an enzyme or a nucleic acid. By "antigen" is meant here a natural or synthetic molecule recognized by antibodies or cells of the immune system and capable of inducing an immune response. An antigen is for example a protein, a peptide, a glycoprotein, a carbohydrate or a lipid.
[0012] By "hapten" is meant here a molecule of low molecular weight capable of being recognized by the immune system, but which is immunogenic only when coupled to a carrier molecule. By "carrier molecule" (or "carrier molecule") is meant especially in the present application a carrier protein or carbohydrate molecule. A carrier molecule may be a natural or non-natural polypeptide (in particular a protein or a peptide) (for example a recombinant protein or a synthetic peptide), a functionalized polymer (of the dextran, polysaccharide or poly-lysine type), a co-polymer or a mixed polymer (in particular a co-polymer of different amino acids, for example a lysine-tyrosine copolymer) or an antibody (in particular a monoclonal antibody or a polyclonal antibody), for example an immunoglobulin (also called Ig). An example of a carrier molecule is BSA (bovine serum albumin). An analyte or at least one of the analytes is preferably a compound for diagnosing a condition of a subject, pathological or otherwise, or diagnosing the risks of developing a condition, pathological or otherwise. An example of a non-pathological condition is a pregnancy.
[0013] The subject may be a human, a non-human animal or a plant. The non-human animal is preferably a mammal, such as a cat, dog, monkey, rabbit, mouse, rat. The term "man" is used broadly and includes a man or woman of any age, such as an infant, a child, a teenager, an adult or an elderly person. When the analyte or at least one analyte is an antigen, it is preferably an antigen for diagnosing an infection, for example an infection caused by a virus, bacteria, fungus or parasite. When the analyte or at least one analyte is an antibody, it is preferably an antibody for diagnosing an infection, for example an infection caused by a virus, bacteria, fungus or parasite. Typically, it may be one or more antigen (s) and / or one or more specific antibodies (s) of: a virus, such as HIV (Human Immunodeficiency Virus), in particular HIV- 1 or HIV-2, HBV (Hepatitis B Virus), HCV (Hepatitis C Virus), HPV (Human Papillomavirus), HTLV (Human T-lymphotropic Virus), in particular HTLV-I or HTLV-II a parasite, such as a parasite capable of causing Toxoplasmosis (in particular Toxoplasma gondii), Malaria (in particular a parasite of the genus Plasmodium, for example Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae or Plasmodium knowlesi) or Chagas disease (in particular Trypanosoma cruzi), in a human or a non-human animal, or a bacterium, such as a bacterium capable of causing syphilis (in particular Treponema pallidum) or Lyme disease (in particular a bacterium of the genus Borrelia), in a man or a non-human animal. By "parasite" is meant here a metazoan or protozoan parasitizing an organism and causing parasitosis. A parasite within the meaning of the invention is therefore neither a virus, nor a bacterium, nor a fungus.
[0014] The analyte or at least one of the analytes may also be a marker of a disease, such as a marker of cardiovascular disease or a marker of diabetes, a marker of the course of a disease, such as hepatitis, a marker of the course of an infection caused by a virus, a bacterium, a fungus or a parasite, a marker of resistance to a treatment, for example an antiviral treatment, an antibiotic treatment or a treatment against cancer .
[0015] Several (eg, two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen or more than sixteen) analytes as described herein can be detected simultaneously in a sample during a multiplex analysis method. This can make it possible to diagnose, in the same sample, one or more infection (s) or disease (s), the evolution of an infection or disease, a condition (pathological or not), a risk of developing a condition (pathological or not) or a resistance marker to a treatment, in a subject. The analytes detected during a multiplex analysis method may be of the same kind (for example, only antibodies or only antigens) or of a different nature (for example, at least one antigen and at least one antibody). Capture Ligand A capture ligand is a compound fixed on a solid support at a spot. At least one capture ligand is specific for an analyte to be detected in the sample. A capture ligand may be an antibody, an antigen, a peptide, a carbohydrate, a lipid or a nucleic acid.
[0016] A capture ligand is preferably an antibody or an antigen. When a capture ligand is an antibody, it is for example a monoclonal antibody or a polyclonal antibody. Detection Ligand A detection ligand is intended to reveal the presence of a compound of which it is specific. A detection ligand can be an antibody, an antigen, a peptide, a carbohydrate, a lipid or a nucleic acid. A detection ligand is preferably an antibody or an antigen.
[0017] When a detection ligand is an antibody, it is for example a monoclonal antibody or a polyclonal antibody. A detection ligand is preferably a labeled detection ligand, i.e., a ligand to which a detection label is attached, covalently or otherwise. When a detection ligand is not labeled, its detection can be achieved by using a labeled antibody specific for said detection ligand.
[0018] At least one detection ligand is specific for an analyte to be detected in the sample. A detection ligand may be identical to the capture ligand or to one of the capture ligands used, with the exception of the possible presence of a detection marker, and / or to bind to the compound of which it is specific at the level of the same area as that bound by the capture ligand or one of the capture ligands. In this case, if said capture ligand and said detection ligand are antibodies, then it is a "homologous sandwich". A capture ligand and the detection ligand or one of the detection ligands may be specific for distinct zones at the level of the compound of which they are specific, so as to avoid a competition of the capture ligand and the detection ligand with respect to of the compound of which they are specific, because of a steric hindrance. In this case, if said detection ligand and said capture ligand are antibodies, then it is a "heterologous sandwich".
[0019] In a preferred embodiment, a detection ligand and a capture ligand specific for the same compound do not bind at the same location on said compound. More preferably, said detection ligand binds to an area of said compound which is remote from the binding area with said capture ligand. In another preferred embodiment, a detection ligand is identical to a capture ligand, except for the possible presence of a detection marker, and / or binds to the compound of which it is specific at the level of the same area as that bound by said capture ligand, when the compound of which it is specific is in the form of a complex having at least two identical binding areas.
[0020] Detection Marker A detection marker can be a direct marker or an indirect marker. A direct marker is a marker whose signal can be detected directly, that is to say without requiring the prior addition of a protractor. A direct marker is, for example, selected from the group consisting of a fluorophore, a luminescent compound, fluorescent or luminescent nanoparticles. A "luminescent" compound may be an electroluminescent compound, a thermoluminescent compound or a chemiluminescent compound. In a preferred embodiment, the luminescent compound is a chemiluminescent compound.
[0021] An example of a luminescent compound (more specifically a thermoluminescent compound) that can be used as a direct marker consists of silica nanoparticles comprising (for example doped or doped) doped molecules. a dioxetane compound, in particular the 1,2-dioxetane compound, or a derivative of a dioxetane compound, for example a 1,2-dioxetane derivative.
[0022] An indirect marker is a marker whose signal detection previously requires the addition of a reporter (also called first reporter) and, if said reporter is itself coupled to an indirect detection marker, the addition of a second reporter of the indirect detection marker coupled to said first reporter. An indirect marker is, for example, selected from the group consisting of an enzyme, a ligand of a ligand-receptor pair, a receptor of a ligand-receptor pair, a hapten, an antigen and an antibody. A ligand or receptor of a ligand-receptor pair is, for example, biotin, a biotin analogue, avidin, streptavidin, neutravidin or digoxigenin.
[0023] A reporter is a substrate of an indirect marker or a molecule specifically binding to an indirect marker, said molecule being itself a direct or indirect marker or itself being coupled to a direct or indirect marker. A substrate is, for example, the substrate of an enzyme. A molecule specifically binding to an indirect marker is, for example, a ligand or receptor of a ligand-receptor pair, such as biotin, a biotin analogue, avidin, streptavidin, neutravidin or digoxigenin . A reporter of an enzyme is for example the substrate of said enzyme. A reporter of a molecule for producing a luminescent compound is for example a substrate, an enzyme or a catalyst.
[0024] A reporter for biotin is, for example, avidin, streptavidin or neutravidin, preferably coupled to a direct or indirect marker, such as an enzyme. Preferred indirect markers according to the invention are biotin and an enzyme, preferably an enzyme producing a luminescent compound by reaction with a substrate. An example of an enzyme is a peroxidase, for example horseradish peroxidase (HRP), a luciferase or an alkaline phosphatase. A preferred biotin reporter according to the invention is streptavidin coupled to a peroxidase, preferably horseradish peroxidase.
[0025] By way of example, if the reporter (also called the first reporter) of the indirect detection marker coupled to an analyte detection ligand is coupled to a peroxidase enzyme, it is necessary to add in a subsequent step the reporter ( also called second reporter) of this peroxidase enzyme, that is to say a substrate of this enzyme, such as luminol, isoluminol and / or a derivative of luminol or isoluminol. In this case, the second protractor is a substrate.
[0026] Solid support The support (s) used for carrying out an analysis method according to the invention are solid supports. A solid support may be in any material suitable for carrying out a method of analysis. A solid support is for example a support based on a polymer or a mixture of polymers. A suitable solid support according to the invention is, for example, a support of polystyrene, polypropylene, poly (meth) acrylate, polybutadiene or combinations thereof.
[0027] A preferred solid support is polystyrene and / or polypropylene. Another type of suitable solid support according to the invention is, for example, an inorganic solid support, such as glass. A support may for example be in the form of a plate, a microplate, a blade or a membrane.
[0028] A solid support comprises at least one compartment, which is also called an analysis zone. The compartment or compartments of a solid support define the orientation of the solid support. The top of a solid support (also called upper face of the solid support) is located on the side or compartments and therefore on the side of the spot or spots. The underside of a solid support (also called the underside of a solid support) is the opposite face. According to a particular embodiment of the invention, a solid support comprises a single compartment. Said single compartment may be a compartment comprising or consisting of a bottom and one or more walls. Alternatively, said single compartment may be free of walls and then assimilate to the solid support itself. The bottom of the compartment can then consist of the upper face of the solid support. An example of such a solid support comprising a single compartment (comprising or not one or more walls) is a blade or a membrane.
[0029] According to another particular embodiment of the invention, a solid support, which may for example be a microplate, comprises at least two compartments. When a solid support comprises at least two compartments, they are isolated from each other, so that they do not communicate with each other, that is to say so that the fluids (also called solutions) used during the implementation of an analysis method can not flow from one compartment to another during the analysis process. Thus, an added solution in one compartment does not go into the other compartments. For example, the compartment or compartments comprise or consist of a bottom and one or more walls, the one or more walls isolating the compartment or compartments from each other so that they do not communicate with each other. A solid support is preferably a microplate. In this case, an example of a compartment is a well. The microplate is typically a 96-well or 384-well microplate.
[0030] In a particular embodiment, when a solid support comprises at least two compartments, they can further be isolated from each other, so that a signal emitted at a compartment is not, in part or in all detected in another compartment. For this purpose, the wall or walls of the compartment or compartments may comprise or consist of an opaque material.
[0031] By "opaque material" is meant in particular a material that does not substantially allow or leave the signal to be detected corresponding to the presence of an analyte. By "not substantially permitting the signal to be detected" is meant that the opaque material passes at most 20%, preferably at most 15%, more preferably at most 10%, more preferably at most 5%, and more preferably still at most 2%, at most 1% or at most 0.5% of the signal to be detected. An example of an opaque material is a black material. In another particular embodiment, when a solid support comprises at least two compartments, the wall or walls of the compartment or compartments comprise or consist of a transparent material.
[0032] In another particular embodiment, when a solid support comprises at least two compartments, the, or the compartments may comprise at least one wall made of a transparent material and at least one wall made of an opaque material. By "transparent material" is meant in particular a material allowing at least 80% of a signal to be detected corresponding to the presence of an analyte, preferably at least 85% of the signal to be detected, more preferably at least 90% of the signal to be detected to be detected. signal to be detected, more preferably at least 95% of the signal to be detected. In a preferred embodiment, the bottom of the one or more compartments of a solid support comprises or consists of a transparent material, in order to allow the detection of the signal to be detected corresponding to the presence of an analyte by the bottom of the compartment. . Examples of opaque material are colored glass, colored polystyrene, colored polyethylene, colored polypropylene and combinations thereof. Examples of transparent material are glass, polystyrene, polymethylpentene, polycarbonate, acrylonitrile butadiene styrene, polymethylmethacrylate or combinations thereof. Typically, at least one (for example one or two) compartment of a solid support is used per sample to be analyzed.
[0033] In a particular embodiment of the invention in which a solid support (for example a slide or a membrane) comprises a single compartment, at least one (for example one or two) solid support is used per sample to be analyzed. A compartment of a solid support used for analyzing a sample comprises at least one spot, at least two spots, at least three spots, for example three spots, four spots or five spots, or at least six spots, preferably six spots, seven spots, eight spots, more preferably at least nine spots, for example nine spots, ten spots, eleven spots, twelve spots, thirteen spots, fourteen spots, fifteen spots, sixteen spots or more than sixteen spots.
[0034] By "spot" is meant here an area located on the bottom surface of a compartment of a solid support comprising at least one compound of interest. The compound (s) of interest may be attached to the bottom surface of a compartment by non-covalent physicochemical interactions (for example of weak bonds, and in particular ionic, van der Waals, hydrogen and / or hydrophobic type). and / or by covalent bonds.
[0035] A spot may comprise, in addition to the compound (s) of interest, at least one polymer, in particular at least one polymer comprising hydrophilic groups, for example at least one hydrogel. By "at least" is meant in this application one or more, "several" meaning in particular two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen or more than sixteen.
[0036] A spot corresponds to a well-defined zone, generally of small size, for example ranging from 0.0078 mm 2 to 5.309 mm 2, preferably from 0.196 mm 2 to 3.142 mm 2, more preferably from 0.503 mm 2 to 2.011 mm 2. A spot may be disc-shaped or approximately disc-shaped, for example oval, particularly when a solid support is a microplate or a slide. Alternatively, a spot may be square or rectangular (especially a band), for example when a solid support is a membrane, or any other form.
[0037] The spots are obtained by techniques well known to those skilled in the art (see, for example, US Pat. No. 7,470,547, US Pat. No. 6,576,295, US Pat. No. 5,916,524 or US Pat. No. 5,743,960). For example, a spot is obtained by depositing at least one drop of a solution containing a determined amount of said compound (s) of interest at a specific location on the surface of the compartment. When a spot comprises at least one polymer (for example at least one hydrogel), said spot can be obtained by depositing at least one drop of a solution containing a determined quantity of said compound (s) of interest at a specific location on the surface of the compartment on which said polymer has been deposited beforehand.
[0038] A spot can also be obtained by in situ synthesis of said compound (s) of interest at a specific location on the surface of the compartment. Said compound (s) of interest are in this case qualified probe. It may be a nucleic acid or a peptide (see for example US 5,143,854). The compound of interest can be, for example, a capture ligand, a carrier molecule coupled to an indirect marker, an indirect marker or a fluorophore. In a preferred embodiment, at least one spot of a compartment comprises at least one capture ligand specific for an analyte to be detected. In an advantageous embodiment, at least one spot of a compartment, preferably all the spots of a compartment, comprise at least two compounds of interest, one of these compounds of interest being a fluorophore. Said fluorophore is then used in particular to control the presence, location and / or integrity of the spots at the end of an analysis process, in particular a multiplex analysis method. For example, at least one spot of a compartment comprises at least one detection ligand specific for an analyte and at least one fluorophore.
[0039] In an advantageous embodiment, each compartment of a solid support comprises the same number of spots. In addition, each compartment of a solid support may comprise the same number of spots and the same spot composition. In another advantageous embodiment, a support may comprise one or more compartments without spot, or with a number and / or a different spot composition (s). A solid support may for example comprise at least two distinct groups (or types) of compartments, each of the distinct groups having a number and / or a different spot composition (s). A compartment generally comprises at least one spot per analyte to be detected, each analyte can for example correspond to an infection or a disease to be detected, to the evolution of an infection or disease, to a condition (pathological or not) of a subject, to a risk of developing a condition (pathological or not) or to a marker of resistance to a treatment. Several spots of a compartment may also be intended for the analysis of the same analyte.
[0040] The same spot can comprise several different capture ligands (for example several antibodies and / or antigens), which are for example specific for the same infection or disease to be detected (in particular specific for the same virus, the same bacterium or the same parasite), or specific to the same evolution of an infection or disease, the same condition (pathological or not) of a subject, the same risk of developing a condition (pathological or not) ) or the same resistance marker to a treatment. In an advantageous embodiment, a compartment comprises at least one control spot, making it possible to validate at least one step of an analysis method, in particular a multiplex analysis method.
[0041] Signal detection Signal detection depends on the type of marker used. The detected signal is electromagnetic radiation. The electromagnetic radiation may be light, for example ultraviolet radiation, visible light or infrared radiation. Ultraviolet radiation is electromagnetic radiation of wavelength at 380 nm. Visible light is electromagnetic radiation with a wavelength ranging from 380 nm to 780 mm. Infrared radiation is electromagnetic radiation with a wavelength of 780 nm to 1 mm.
[0042] The expressions "signal detection" and "signal acquisition" are synonymous here.
[0043] By "signal detection" is meant in particular the detection of a signal corresponding to the presence of an analyte or the detection of a signal corresponding to a control of the process. The person skilled in the art knows how to detect a signal at a spot according to the detection marker or markers used. The signal is for example detected by means of a camera which captures the image of the bottom of the solid support. The detection of the signal generally comprises a measurement of the signal intensity, for example expressed in RLU (Relative Light Unit). The signal emitted by a direct fluorophore type marker can be read directly in fluorescence, after excitation by a light energy. Indeed, a fluorophore, also called fluorochrome or fluorescent molecule, is a chemical substance capable of emitting fluorescence light after excitation with light energy. As indicated above, an indirect marker, for example of the enzyme or biotin type, requires the addition of a reporter, the reporter can be coupled to a direct or indirect marker. If a reporter is itself coupled to an indirect marker, for example an enzyme, it is necessary to add in a subsequent step a reporter of this indirect marker, for example the substrate of this enzyme.
[0044] In the context of the present invention, the dye (s) used must be present during the detection of the signal and the detection of the signal is carried out in the presence of a liquid phase. By using a dye according to the invention, it is possible to reduce the background noise and in particular to improve the "detected signal on background noise" ratio, by detecting the signal corresponding to the presence of an analyte emitted at the level of the spots from underneath the solid support. In a preferred embodiment, the signal detected in the analysis method according to the invention is a signal emitted in chemiluminescence by a chemiluminescent compound.
[0045] Chemiluminescence is a chemical reaction resulting in the production of light. A reaction of this type is the oxidation-reduction of luminol (3-aminophthalhydrazide, also called 5-amino-2,3-dihydro-phthalazine-1,4-dione, of empirical formula C8H7N302), isoluminol or a derivative of luminol or isoluminol with an oxidant, for example oxygenated water or any hydroxide. During a chemiluminescence reaction, the molecule produced by the reaction is in an excited state: it is the chemiluminescent compound. It is the return of this chemiluminescent compound to the ground state which causes the emission of light. In a preferred embodiment, the detected chemiluminescent signal is emitted by the reaction of a peroxidase enzyme with its substrate, for example luminol, isoluminol (also called 4-aminophthalhydrazide) and / or a derivative of luminol or isoluminol. This reaction also requires the presence of an oxidant and, where appropriate, an electron mediator. A derivative of luminol or isoluminol is preferably a molecule obtained from luminol or isoluminol by any possible modification (s) (for example chemical and / or enzymatic). A derivative of luminol or isoluminol is in particular a substrate for a peroxidase enzyme, the reaction of said peroxidase enzyme with said luminol derivative or isoluminol for the production of a chemiluminescent compound. A derivative of isoluminol may be, for example, aminoethylisoluminol (or AEI), aminoethylethylisoluminol (or AEEI), aminobutylisoluminol (or ABI), aminobutylethylisoluminol (or ABEI), aminopentylethylisoluminol (or APEI), aminohexylisoluminol (or AHI), aminohexylethylisoluminol (or AHEI), aminooctylmethylisoluminol (or AOMI) or aminooctylethylisoluminol (or AOEI), as described in the publication Dodeigne C. et al (2000), Talanta 51, 415-439, "Chemiluminescence as diagnostic tool. A review ». According to another particular embodiment, the signal detected in chemiluminescence is emitted by an enzymatic or chemical reaction with a substrate chosen from an acridine, coelenterazine, dioxetane or peroxyoxalic compound, or a derivative thereof, and in particular a compound described in US Pat. publication Dodeigne C. et al (2000), Talanta 51, 415-439, Chemiluminescence as diagnostic tool. A review ». An electron mediator is, for example, sodium 3- (10'-phenothiazinyl) propane-1-sulfonate, p-iodophenol, p-iodophenylboronic acid, 4- (phenothiazine-10-yl) butane- 1-sulfonic, or combinations thereof. An oxidant is, for example, a peroxide, for example a hydrogen peroxide, or sodium perborate. The signal resulting from the reaction of a peroxidase enzyme with luminol, isoluminol and / or a derivative of luminol or isoluminol is read at a wavelength of 375 nm to 580 nm, for example 425 nm . The detected signal is preferably expressed in RLU (Relative Light Unit).
[0046] The peroxidase enzyme may be coupled to a detection ligand, for example an analyte-specific detection ligand, or a reporter of an indirect detection marker, such as streptavidin. Generally, the chemiluminescence reaction is carried out by means of a kit comprising at least two solutions.
[0047] The first solution comprises the peroxidase substrate, for example luminol, isoluminol and / or a derivative of luminol or isoluminol, and an electron mediator; the second solution comprises an oxidant. By way of example, it is possible to use the "Immun-star western C" kit (Bio-Rad, United States), "ELISTAR ETA C Ultra ELISA" (Cyanagen, Italy), "Supersignal West Pico" ( Thermo Scientific, USA), "Chemiluminescent Sensitive Plus HRP" (Surmodics, USA). Fluorophore used as a control In an advantageous embodiment, the spot or spots of at least one compartment of a solid support comprise a fluorophore used as a control.
[0048] The fluorophore used as a control preferably does not interfere with the signal corresponding to the presence of an analyte, for example with the signal emitted by a chemiluminescent compound. By way of example, when the signal corresponding to the presence of an analyte is a chemiluminescent compound obtained from luminol, isoluminol and / or a derivative of luminol or isoluminol, the fluorophore used as the The control preferably emits no light at around 425 nm, in particular from 400 nm to 550 nm, preferably from 375 nm to 550 nm, more preferably from 350 nm to 580 nm. It may, for example, emit light only at wavelengths lower (or lower or equal) than 400 nm, 390 nm, 380 nm, 375 nm, 370 nm, 360 nm or 350 nm, or only wavelengths greater (or greater or equal) at 550 nm, 560 nm, 570 nm, 580 nm, 590 nm or 600 nm. A fluorophore used as a control is, for example, selected from the group consisting of a coumarin, a rhodamine, a carbopyronine, an oxazine, β-phycoerythrin, a benzopyrylium derivative and their derivatives.
[0049] A preferred fluorophore that can be used in the spots as a control is, for example, a carbopyronine comprising the following basic structure: ## STR1 ## By way of example, mention may be made of Atto 633 carbopyronine marketed by Atto-Tec and its derivatives. Another example of a preferred fluorophore that can be used in spots as a control is the fluorophore marketed by the company Dyomics under the name "Dye 634" (in form coupled to a carrier molecule, for example BSA), the formula of which is the following: 3Na + Dye By "dye" is meant here a soluble compound which absorbs light in a wavelength range covering all or part of the signal wavelength range of the signal being sought to be reduced ( partially or totally), ie of the signal at the origin of the light interferences. When a luminescent compound, for example a chemiluminescent compound, is used in an assay method to detect the presence of an analyte, a dye according to the invention preferably absorbs light in a range of wavelengths. completely covering the emission wavelength range of said luminescent compound. Typically, for a visualization system using the reaction of a peroxidase on luminol, isoluminol and / or a derivative of luminol or isoluminol, the dye according to the invention preferably absorbs a range of length of d wave ranging from 375 nm to 580 nm.
[0050] When a fluorophore is used in an assay method to detect the presence of an analyte in a sample and, optionally, to quantify an analyte in a sample, the dye used is compatible with the detection of the signal emitted by said fluorophore. Thus, the dye used does not absorb light in a wavelength range corresponding to the range of wavelengths of excitation and / or emission of said fluorophore and, preferably, does not diffuse corresponding light. at the wavelength range of excitation and / or emission of said fluorophore. In a preferred embodiment, the dye (s) are not fluorescent in the red, i.e. they do not emit light at wavelengths between 620 and 780 nm when are excited by any light, especially in basic medium. For example, a preferred dye according to the invention does not absorb at 657 nm and, in particular, does not absorb between 620 and 800 nm, between 610 and 850 nm or between 600 and 900 nm or between 580 and 950 nm, and is not itself fluorescent.
[0051] Surprisingly, the dye according to the invention absorbs the signal at the origin of the light interferences, without interfering or interfering little with the signal to be detected, for example by not interfering little or not with the light emitted by the chemiluminescent compound from the reaction of a peroxidase enzyme with luminol, isoluminol and / or a derivative of luminol or isoluminol locally at the spots.
[0052] The expression "the compound X does not interfere with or interferes with a signal" signifies here that the intensity of the signal in the presence of the compound X is decreased by at most 20%, preferably at most 15%, more preferably still at most 10%, relative to the intensity measured in the absence of said dye (s). Furthermore, the dye (s) according to the invention do not induce energy transfer with the chemiluminescent compound, as can be observed with fluorescein which can pass into an activated state and emit at a wavelength greater than the emission wavelength of the chemiluminescent compound produced by the reaction of a peroxidase enzyme with its substrate (for example, luminol, isoluminol and / or a derivative of luminol or isoluminol).
[0053] In an advantageous embodiment, a dye according to the invention also makes it possible to detect the signal emitted by a fluorophore present as a control in the spots. Such a dye is, for example, obtained or obtainable by the method of selecting a dye as defined below in the "dye selection process method further allowing the detection of the signal emitted by a dye. fluorophore present in the spot or spots as control.
[0054] A dye according to the invention is, for example, selected from the group consisting of tartrazine, quinoline yellow, naphthol yellow S, curcumin, riboflavin and riboflavin 5 'phosphate. Thus, surprisingly, the dye (s) according to the invention thus make it possible to partially or totally reduce the light interferences originating from a chemiluminescent compound without interfering or interfering little with the signal to be detected in chemiluminescence and, where appropriate, by allowing the detection of the fluorescence emitted by a fluorophore present in the spots as a control. The inventors have shown that the use of a single dye, in particular tartrazine, makes it possible to improve (and thus secure) the detection of the signal in a spot analysis method (s), in particular of a multiplex analysis method, and this without interfering with the signal emitted by a fluorophore possibly present in the spots. Those skilled in the art can easily determine the optimum amount of dye (s) to be used in a spot analysis method (s), in particular a multiplex analysis method, to obtain improved detection of the dye. desired signal, for example by testing several concentrations of the dye (s). The present invention also relates to a method for selecting a dye which furthermore makes it possible to detect the signal emitted by a dye which can also be used to detect the signal emitted by a fluorophore present in the spot or spots. a fluorophore present in the spot or spots of a solid support, said process comprising the following steps: a) putting a liquid phase comprising a test dye or a mixture of test dyes in contact with the spot or spots of a compartment; a solid support, at least one of the spots of said compartment comprising a fluorophore, b) detecting a signal emitted by said fluorophore in the presence of said liquid phase comprising said test dye or said dye mixture to be tested, and c) selecting a dye or a mixture of dyes in the presence of which the signal detected in step b) makes it possible to locate the spot or spots comprising said fluorophore. The dye to be tested or included in the test mixture is a soluble compound that absorbs light in a range of wavelengths that partially or wholly cover the signal wavelength range of the signal being sought. reduce (partially or totally), ie the signal causing the light interference. Step a) is carried out for each dye or dye mixture to be tested. In step a), a same test dye or mixture of test dyes may be added in several compartments, for example at different concentrations, to test different concentrations of said dye or said dye mixture. A different compartment is used for each dye to be tested or a mixture of different dyes to be tested.
[0055] Absorbent composition based on at least one dye In an advantageous embodiment, the dye as defined above in the "dye" paragraph is provided in the form of an absorbent composition. An absorbent composition according to the invention is an aqueous solution comprising at least one dye.
[0056] A preferred absorbent composition comprises only one dye. For example, a preferred absorbent composition comprises tartrazine as the sole colorant. The absorbent composition according to the invention may comprise from 100 μg / ml to 3000 μg / ml of dye, preferably from 200 μg / ml to 2500 μg / ml of dye, more preferably from 250 μg / ml to 2000 μg / ml of dye. for example from 250 μg / ml to 500 μg / ml or from 1000 μg / ml to 2000 μg / ml. For example, the absorbent composition may comprise 250 μg / ml, 500 μg / ml, 1000 μg / ml or 2000 μg / ml dye. The absorbent composition according to the invention may comprise from 0.187 mM to 5.614 mM of dye, preferably from 0.374 mM to 4.678 mM of dye, more preferably from 0.468 mM to 3.743 mM of dye, for example from 0.468 mM to 0.936 mM or from 1.871 mM. mM at 3.743 mM. For example, the absorbent composition may comprise 0.468 mM, 0.936 mM, 1.871 mM or 3.743 mM dye. Advantageously, the absorbent composition comprises a dye or at least one dye and at least one compound involved in the production of a chemiluminescent compound. Such an absorbent composition has the advantage of being stable over time. The expression "stable over time" means that, when carrying out the same analysis method, the signal detected using an absorbent composition at OJ is substantially identical to the signal detected using said absorbent composition after storage of said absorbent composition for at least one month at 4 ° C and / or at 37 ° C, preferably for at least 3 months at 4 ° C, for example for 3 months, 6 months, one year or two years at 4 ° C, ° C. The expression "substantially identical" means that the detected signal varies at most 40%, preferably at most 30%, more preferably at most 20%.
[0057] The absorbent composition may be mixed with one or more compositions and / or one or more compounds used in the context of an analytical method, in particular used during the revelation step (s). In an advantageous embodiment, the absorbent composition according to the invention further comprises at least one compound selected from the group consisting of luminol, isoluminol, a derivative of luminol or isoluminol, an electron mediator and an oxidant. Luminol, isoluminol, luminol derivative or isoluminol, the peroxidase enzyme, the electron mediator and the oxidant are in particular as defined above. A preferred absorbent composition comprises at least one dye, for example tartrazine, at least one compound selected from luminol, isoluminol or a derivative of luminol or isoluminol, and optionally an electron mediator. Another preferred absorbent composition comprises at least one dye, for example tartrazine, and at least one oxidant, for example a peroxide. The absorbent compositions according to the invention advantageously comprise at least one solvent. A solvent used in the absorbent composition is preferably compatible with an enzymatic reaction leading to the production of a luminescent compound, such as the reaction of peroxidase with luminol, isoluminol and / or a derivative of luminol or isoluminol. A preferred solvent for use in the absorbent composition is water. Another example of a preferred absorbent composition comprises at least one dye, for example tartrazine, and does not include luminol, isoluminol, derivative of luminol or isoluminol, electron-mediator, or oxidizer. For example, such an absorbent composition comprises or consists of at least one dye, for example a single dye, and a solvent, for example water. Improved signal detection The use of at least one dye such as as defined above or an absorbent composition comprising it as defined above makes it possible to improve (and thus secure) the detection of the signal in a spot analysis method (s), preferably a method of multiplexed spot analysis, in particular when the signal is detected in the presence of a liquid phase. By "improving the signal detection" is meant in particular the reduction of the background noise, and more particularly the improvement of the "signal detected on background" ratio, in the presence of at least one dye or the absorbent composition comprising, with respect to the ratio "signal detected on background noise" obtained in their absence. The "detected signal" for evaluating the improvement of the "signal detected on background noise" ratio is, for example, the intensity of the signal measured at a given spot (ie at the location of said spot). in the presence of an analyte to be detected in a sample or measured at a given spot (ie where said spot is located) in the presence of a known amount of an analyte to be detected. Preferably, the "detected signal" for evaluating the improvement of the "signal detected on background noise" ratio is the intensity of the signal measured at a given spot (ie at the location of said spot) in the presence of an analyte present in an amount which, in the absence of a dye, induces luminous interferences, such as a luminous arc, a twin spot and / or a luminous veil. The intensity of the signal measured at a spot is generally expressed in RLU (Relative Light Unit). The person skilled in the art knows how to detect the signal at a spot (ie where said spot is located), as a function of the detection marker or markers used, in particular by means of a camera which is advantageously located below the solid support. The "background noise" is the light intensity measured at the bottom areas of a compartment of a solid support that do not include spots.
[0058] Background noise is usually expressed in RLU (Relative Light Unit). An improvement of the "signal detected on background" ratio is present when the ratio "signal detected on background noise" is increased, for example by increasing the detected signal and decreasing the background noise, or by decreasing the detected signal and by further decreasing the background noise.
[0059] The use of a dye according to the invention preferably allows an increase in the ratio "signal detected on background noise", in the presence of the dye (s) versus in the absence of the dye (s), of at least 5. %, preferably at least 10%, more preferably at least 15%, more preferably at least 20%, more preferably at least 25%, for example at least 30%, or at least at least 40%.
[0060] The present invention is particularly suitable for a method of analysis on spot (s), in particular a method of multiplex analysis on spots, based on a revelation in chemiluminescence. Indeed, in order for the signal emitted in chemiluminescence to allow a detection of the capture-analyte-ligand detection ligand interaction by amplification of the signal, it is necessary for the enzymatic reaction to continue during the detection of the signal, and therefore that the substrate of the enzyme is present in a liquid phase at the spot, at the time of detection of the signal. In the context of the present invention, the dye, for example provided in the form of an absorbent composition, must be present at the time of detection of the signal.
[0061] The dye may be added before, at the same time or subsequently to the addition of one or more of the compounds required for the chemiluminescence reaction. In all cases, the dye must be present at the time of acquisition of the signal. The compounds required for a chemiluminescence reaction are generally an enzyme (for example a peroxidase enzyme), a substrate of the enzyme (for example luminol, isoluminol and / or a derivative of luminol or isoluminol), optionally at least one other compound such as an oxidant (for example a peroxide) and / or an electron mediator (for example, sodium 3- (10'-phenothiazinyl) propane 1-sulfonate).
[0062] Process for improving the detection of a signal The present invention is particularly concerned with an analysis method, in particular with a multiplex analysis method, making it possible to improve (and thus to secure) the detection of a corresponding signal. in the presence of an analyte, said method comprising or consisting of the following steps: a) providing a solid support comprising at least one compartment, said compartment comprising at least one spot for the detection of an analyte, b) putting a sample to be analyzed in the presence of the spot or spots of said compartment, c) placing at least one spot of said compartment at least one analyte detection ligand, said analyte detection ligand being coupled to a direct detection marker or indirect, d) when said detection marker is an indirect marker, bringing into the presence of said spot or spots of said compartment a reporter of the indirect detection detector coupled with audi t detection ligand, e) when the reporter used in step d) is coupled to an indirect marker, bringing into the presence or spots of said compartment a reporter of the indirect detection marker coupled to said reporter, f) at least one dye in the presence of the spot or spots of said compartment, said one or more dyes being included in a liquid phase in contact with the spot or spots of said compartment, and g) detecting a signal corresponding to the presence of an analyte at the spot or spots of said compartment, in the presence of a liquid phase comprising said one or more dyes. The method according to the invention preferably comprises first step a); then steps b) and c) which can be performed in this order, or step c) before step b), or else steps b) and c) simultaneously; then step d); then steps e) and f) which can be performed in this order, or step f) before step e), or else steps e) and f) simultaneously; then step g). In a preferred embodiment, step f) is performed simultaneously in step e). No washing step is carried out between step f) and step g) (that step e) is carried out before, after, or simultaneously with step f)), so that the dye is present at the moment of signal detection. When step c) is carried out before step b), there is no washing step between step c) and step b). The expression "putting a compound X in the presence of one or more spots of a compartment" means in particular that the compound X is added in a compartment comprising said spot or spots, said compartment preferably being intended for analyzing a sample, and said compound X preferably being provided in the form of a composition comprising it, such as a solution, a dispersion or a suspension.
[0063] When at least two compounds are to be placed in the presence of the spot or spots of a compartment during the same step and / or when at least two of the steps b) to f) are carried out simultaneously, said compounds can be in the presence of said spot or spots separately, that is to say supplied in the form of separate compositions (in particular in the form of solutions, dispersions or separate suspensions); alternatively, said compounds or some of said compounds may be brought into contact with one or more spots of a compartment in the form of one or more mixtures. The different compounds are brought into contact with the spots of at least one compartment for a certain period of time, for example from 1 second to 2 hours, preferably from 1 minute to 1 hour, more preferably from 5 minutes to 50 minutes, more preferably from 10 to 10 minutes. minutes to 40 minutes.
[0064] Those skilled in the art can determine the appropriate temperature for each incubation step. The temperature of an incubation may for example be 4 ° C, a temperature of 19 ° C to 24 ° C, 37 ° C or 40 ° C. The different constituents used in steps b), c), d) and e) are well known to those skilled in the art. They allow, for example, the formation of antigen-antibody and marker-reporter complexes. The method further comprises one or more washing steps which make it possible to eliminate non-spot-bound compounds or to the various compounds directly or indirectly linked to the spots. Typically, a washing step consists of at least one cycle, preferably at least two cycles, more preferably 3 to 6 cycles, of distribution (for example a volume of 400 μl) and aspiration of a washing solution into each compartment used. . Steps b) to g) are in particular carried out for each compartment of a solid support comprising at least one spot intended for the detection of an analyte, in which a sample is analyzed. Step a) consists in providing a solid support comprising at least one compartment, said compartment comprising at least one spot intended for the detection of an analyte.
[0065] Step a) means in particular that the analysis method is implemented by means of said solid support, that is to say by using said solid support. A solid support is in particular as defined above in the "solid support" paragraph. In an advantageous embodiment, a solid support comprises at least one compartment of which at least one spot comprises a fluorophore as a control of the spot or spots; preferably, a solid support comprises at least one compartment whose spots comprise a fluorophore as spot control. In step b), a sample to be analyzed is placed in the presence of the spot or spots of a compartment of the solid support. The sample to be analyzed and the analyte (s) to be detected are in particular as defined above in the "sample" and "analyte" paragraphs. In step c), at least one analyte detection ligand is brought into contact with the spot or spots of said compartment, said analyte detection ligand being coupled to a direct or indirect detection marker. The detection ligand of an analyte is in particular as defined above. In a preferred embodiment, an analyte detection ligand is coupled to an indirect detection marker selected from the group consisting of biotin, avidin, streptavidin and neutravidin. When the detection marker is an indirect marker, the method comprises a step d) comprising or consisting in placing in the presence of one or more spots of said compartment a reporter (also called first reporter) of the indirect detection marker coupled to said detection ligand, said reporter being himself coupled to a direct or indirect marker. In a preferred embodiment, an indirect detection marker reporter coupled to an analyte detection ligand is selected from the group consisting of biotin, avidin, streptavidin and neutravidin.
[0066] For example, an analyte detection ligand is coupled to biotin and the reporter for biotin is streptavidin coupled to a direct or indirect detection marker. When the reporter (that is to say the first reporter) used in step d) is coupled to an indirect marker, the method further comprises a step e) of placing in the presence or spots of said compartment a reporter (i.e., a second reporter) of the indirect detection marker coupled to said reporter. For example, an analyte detection ligand is coupled to biotin and the biotin reporter is streptavidin coupled to an enzyme. The reporter of the enzyme (i.e. the second reporter) is then the substrate of said enzyme. In step f), at least one dye is brought into contact with the spot or spots of said compartment. The dye is in particular as defined above in the paragraph "dye". The dye is, for example, selected from the group consisting of tartrazine, quinoline yellow, naphthol yellow S, curcumin, riboflavin and riboflavin 5 'phosphate. The dye may be provided in the form of an absorbent composition as defined above in the "absorbent composition" section. In an advantageous embodiment, the dye is provided in the form of an absorbent composition comprising at least one compound selected from the group consisting of luminol, isoluminol, a luminol derivative or isoluminol, a mediator of electrons and an oxidant. When the absorbent composition further comprises at least one compound selected from the group consisting of luminol, isoluminol, a derivative of luminol or isoluminol, an electron mediator and an oxidant, steps e) and f) are therefore performed simultaneously. At the end of step f), the dye (s) are included in a liquid phase in contact with the spot (s) of said compartment. By "liquid phase in contact with the spot or spots of said compartment" here means that a liquid composition is present in said compartment. Said composition may for example be a solution, a dispersion or a suspension. The liquid phase in step f) may comprise or consist of an absorbent composition according to the invention, depending in particular on whether step f) is carried out before step e).
[0067] For example, when step f) is carried out before step e) and step f) is preceded by at least one washing step, the liquid phase in step e) may consist of an absorbent composition . When step f) is carried out simultaneously or after step e), the liquid phase in step e) may comprise the absorbent composition.
[0068] Step g) comprises the detection of a signal corresponding to the presence of an analyte at the spot or spots of said compartment, the detection of said signal being carried out in the presence of the liquid phase comprising said one or more dyes. The liquid phase in step g) may be identical to the liquid phase of step f), especially when step f) is carried out after step e).
[0069] The liquid phase in step g) may be different from the liquid phase of step f), especially when step f) is carried out before step e).
[0070] When the dye is provided as an absorbent composition, the liquid phase in step g) comprises or consists of said absorbent composition. When several different detection markers are used in the analysis method for the detection of the analyte (s), step g) comprises the detection of as many different signals as detection markers used. The signal detected in step g) corresponding to the presence of an analyte is, for example, the signal emitted by a luminescent compound, preferably a chemiluminescent compound, and / or the signal emitted by a fluorophore. Preferably, the signal detected in step g) corresponding to the presence of an analyte is the signal emitted by a chemiluminescent compound. Thus, step g) comprises at least the detection of a signal emitted at the spot or spots of said compartment which corresponds to the presence of an analyte, the signal corresponding to the presence of an analyte being preferably not emitted a chemiluminescent compound.
[0071] In addition, step g) may advantageously comprise the detection of a signal emitted by a fluorophore present as a control in one, several or the spots of at least one compartment of the solid support. One skilled in the art knows how to measure the emitted signal, for example by a luminescent compound or a fluorophore, depending on the nature of said luminescent compound or said fluorophore. The signal is preferably detected in step g) from below the solid support. The detection of the signal preferably comprises a measurement of the intensity of the signal emitted at the spot or spots, the said measurement being preferably made from below the solid support, that is to say at the level of the face. bottom of the solid support.
[0072] The detection of the signal is in particular carried out by means of a camera capturing the image of the bottom of the solid support. The measured signal is therefore the signal passing through the solid support towards the underside of said solid support. The camera may, for example, be directed towards the underside of the solid support or may capture the image from below the solid support by means of an optical system (which may for example comprise or consist of one or more mirrors, a prism and / or in one or more lenses). Measuring the intensity of the signal emitted by a fluorophore requires illuminating the compartment or compartments, preferably from below the solid support, with a light corresponding to the excitation spectrum of the fluorophore.
[0073] The method according to the invention as defined above thus makes it possible to improve the detection of a signal corresponding to the presence of an analyte in a spot analysis method (s), in particular when the detection of the signal is carried out in the presence of a liquid phase. The improvement of the signal detection comprises or consists of a decrease of the background noise, preferably an increase of the "signal detected on background noise" ratio. The ratio "signal detected on background noise" is in particular as defined above. A preferred method for improving the detection of a signal corresponding to the presence of an analyte in a method of analysis, in particular a multiplex analysis method, is a method as defined above comprising the the following steps: a) providing a solid support comprising at least one compartment, said compartment comprising at least one spot intended for the detection of an analyte, said spot comprising a capture ligand of said analyte and, preferably, a fluorophore, b) put a sample to be analyzed in the presence of the spot or spots of said compartment, c) bringing into the presence of said spot or spots of said compartment at least one analyte detection ligand, said analyte detection ligand being coupled to a marker of indirect detection, preferably biotin, d) placing in the presence of one or more spots of said compartment a reporter of the indirect detection marker coupled to said detection ligand, preferably the e) when the reporter used in step d) is coupled to a peroxidase enzyme, bringing into contact with one or more spots of said compartment a substrate of said enzyme, for example luminol, isoluminol and / or a derivative of luminol or isoluminol, el) when the reporter used in step d) is coupled to a peroxidase enzyme, bringing into the presence or spots of said compartment at least one antioxidant, for example peroxide, and optionally at least one electron mediator, for example sodium 3- (10'phenothiazinyl) propane 1-sulfonate, said step el) being able to be carried out before step e), after step e) or simultaneously with step e), f) putting at least one dye, preferably tartrazine, in the presence of the spot or spots of said compartment, said dye or said dyes being included in a liquid phase in contact with the spot or spots of said compartment, step f) can be carried out before or after step e), before or after step e1), or simultaneously with step e) and / or step e1), and g) detecting a signal corresponding to the presence of an analyte at the spot or spots of said compartment, in the presence of the liquid phase comprising said one or more dyes. The present invention particularly relates to the use of at least one dye for improving (and thus securing) the detection of a signal corresponding to the presence of a dye. analyte in a solid support analysis method comprising at least one spot, in particular in a multiplex analysis method. The solid support is in particular as defined above in the "solid support" paragraph. The dye is in particular as defined above in the paragraph "dye". The dye is, for example, selected from the group consisting of tartrazine, quinoline yellow, naphthol yellow S, curcumin, riboflavin and riboflavin 5 'phosphate. The present invention particularly relates to the use as defined above, characterized in that the dye is tartrazine. The dye may be provided in the form of an absorbent composition as defined above in the "absorbent composition" section. In a more preferred embodiment, the subject of the present invention is the use of tartrazine for improving the detection of a signal corresponding to the presence of an analyte in a spot (s) analysis method, particularly in a method of multiplex analysis on spots.
[0074] The present invention more particularly relates to the use as defined above, characterized in that the detection of a signal corresponding to the presence of an analyte is carried out in the presence of a liquid phase. The detection of the signal preferably comprises a measurement of the intensity of the signal emitted at the spot or spots, said measurement preferably being made at the level of the underside of the solid support. The detection of the signal is in particular carried out by means of a camera capturing the image of the bottom of the solid support. As indicated above, the camera may, for example, be directed towards the bottom of the solid support or may capture the image from below of the solid support by means of an optical system (which may for example comprise or consist of a or several mirrors, in a prism and / or in one or more lenses).
[0075] The present invention particularly relates to the use as defined above, characterized in that the signal ratio detected on background noise is increased. The ratio "signal detected on background noise" is in particular as defined above.
[0076] The present invention preferably relates to the use as defined above, characterized in that the signal corresponding to the presence of an analyte is a signal emitted by a chemiluminescent compound and / or a fluorophore. The subject of the present invention is also the use as defined above in which the analysis method is implemented by means of a solid support as defined above, in particular of a solid support comprising at least one at least one compartment of which at least one spot comprises a fluorophore as a spot control, preferably a solid support comprising at least one compartment whose spots comprise a fluorophore as spot control.
[0077] Other characteristics and advantages of the invention will emerge more clearly from the examples which follow, given by way of illustration and not limitation. These examples and figures illustrate the invention without limiting its scope.
[0078] Figures Figure 1: Schematic cross-section of a well of a microplate. Three real spots are represented on the bottom of the well which consists of a transparent film. The hollow arrows pointing downwards show the really useful emission that goes towards the camera. The solid arrows represent the path of the light rays in the well. These arrows illustrate the presence of light artifacts that originate light scattering in the liquid medium, reflections on the wall of the well and at the interface liquid / air and meniscus. Figure 2: Schematic cross-section of a well of a microplate. Three real spots are represented on the bottom of the well which consists of a transparent film.
[0079] The hollow arrows pointing downwards show the really useful emission that goes towards the camera. The solid arrows represent the path of light rays in the well and the intensity of these rays. The horizontal lines represent the dye that absorbs the light emitted into the liquid medium, thus reducing the light scattering in the liquid medium and the light artifacts at the well walls and at the liquid / air interface. at the level of the meniscus.
[0080] Figure 3: Image of a well with sample S1, without addition of tartrazine. 1: twin bright spot slightly smaller than the actual spot, result of the reflection of the actual spot on the surface of the liquid in the background. 2: bright ring. 3: bright arc. Figure 4: Image of a well with sample S1, with 250 μg / ml tartrazine.
[0081] Figure 5: Image of a well with sample S1, with 500 μg / ml tartrazine. Figure 6: Image of a well with sample S1, with 1000 μg / ml tartrazine. Figure 7: Image of a well with sample S1, with 2000 μg / ml tartrazine. Figure 8: Image of a well with sample S1, with 4000 μg / ml tartrazine. Figure 9: Intensities normalized to the baseline light level reference condition (lower curve) and reference spot signal (upper curve), as a function of tartrazine concentration (μg / ml). Figure 10: Improvement of the detected signal to background ratio ratio as a function of the tartrazine concentration (μg / ml). Figure 11: Detection of fluorescence spots in the presence of the dye, said spots comprising a fluorophore as a control.
[0082] Examples Materials and Methods A multiplex analysis method is carried out using a 96-well microplate comprising 9 spots per well (3 spots numbered from 1 to 3 on the 1st line, 3 spots numbered from 4 to 6 on the 2nd line and 3 spots numbered from 7 to 9 on the 3rd line). Spot number 9 is a reference spot (or spot Aref) that includes a carrier molecule bound to biotin. This reference spot makes it possible, among other things, to validate the revelation step. Spot # 2 comprises a specific capture ligand corresponding to the analyte AH which is present in high concentration in the reference sample S1 used. During the analysis process, the sample S1 is brought into contact with the spots of a well for 40 minutes at 37 ° C. After washing the pLits, a specific detection ligand corresponding to the analyte AH present in the reference sample S1 and coupled to the biotin is added to the well. After 15 minutes of incubation at 37 ° C, the well is washed and the streptavidin reporter coupled to a peroxidase enzyme is added to the well. After 15 minutes of incubation at 37 ° C, the well is washed. The kit "ELISTAR ETA C Ultra ELISA" (Cyanagen, Italy) is used for the revelation step, according to the manufacturer's manual. It consists in providing two solutions: a solution A which comprises the substrate of the enzyme, ie luminol and an electron mediator (sodium 3- (10'-phenothiazinyl) propane-1-sulfonate) and a solution B which comprises an oxidant (peroxide solution). Before the signal is acquired, a solution comprising tartrazine is added, if necessary, to the wells, in the form of a mixture with solution B. After incubation for one minute with stirring at 37.degree. signal is detected.
[0083] The signal emitted in chemiluminescence by the chemiluminescent compound resulting from the enzymatic reaction is measured by means of an image taken by a CCD camera through a telecentric lens from below the microplate. The brightness level of the bottom of the wells is measured on the same image. For the measurement of the fluorescence signal, a lighting system emitting a red light centered on the wavelength of 620 nm illuminates the underside of the solid support homogeneously. A filter placed at the entrance of the camera and having a bandwidth centered on 680 nm makes it possible to cut this red excitation light. It lets in the light emitted by the fluorophore present in the spots. The signal emitted fluorescence by the spots is measured using this device. Results (i) Improvement of the detection of the signal in the presence of the dye In the case of the sample S1, a very intense light is emitted at the spot AH (spot number 2 in the grid of spots). In the reference condition in the absence of tartrazine (see FIG. 3), a light spot (1) is slightly offset from the reference spot (9th spot in the spot grid, called the Aref spot). lower, result of the reflection of the reference spot at the surface of the liquid in the background. In addition, a luminous ring (2) is observed all around the bottom of the well, resulting from the image of the vertical wall of the well perceived through the liquid acting as a plane-concave lens. The ring can be extremely intense near the bright AH spot and thus present a bright arc (3). A luminous veil over the entire bottom of the well is also present. In the conditions with tartrazine, we notice the disappearance of the reflection of the spot previously observed and the disappearance of the light ring on the perimeter of the well, as well as the reduction of the veil (see Figures 4 to 8). The intensity of the reference spot signal and the level of brightness of the bottom of the well were measured in RLU (Relative Light Unit) numbers (see Table 1 and Figure 9). Table 1: Reference Spot Signal Strength and Bottom Light Level Concentration Intensity of Intensity of Spot Intensity Intensity of Tartrazine Bottom of Spot Background Reference of (pg / m1) sink (RLU) (RLU) ( %) reference (%) 0 77 3168 100.0`) / 0 100.0`) / 0 250 53 2784 68.8% 87.9% 500 47 2592 61.0% 81.8% 1000 40 2262 51, 9% 71.4% 2000 31 1854 40.3% 58.5% 4000 33 1455 43.0% 46% Luminous intensities are observed to decrease when increasing amounts of tartrazine are added. The interesting effect is that the background brightness level decreases faster than the reference spot signal level. The brightness of the bottom of the well is considered undesirable, generating a noise in the measurement of the signal that one seeks to quantify. It can be concluded that the signal-to-noise ratio is improved by adding tartrazine.
[0084] Table 2: Signal Intensity and Brightness Level Concentration Well Bottom Intensity (RLU) Intensity of the Intensity Ratio Improvement of Tartrazine Spot Signal Spot (pg / ml) Reference Reference on Noise (%) (in RLU) well-bottom intensity 0 77 3168 41.14 0.0% 250 53 2784 52.53 27.7% 500 47 2592 55.15 34.0% 1000 40 2262 56.55 37.4% 2000 31 1854 59.81 45.4% 4000 33 1455 44.09 7.2% Table 2 and Figure 10 show the improvement of the signal-to-background ratio when increasing the tartrazine concentration. An optimum appears to exist at a concentration less than or equal to 2000 μg / ml tartrazine. Beyond this concentration, the signal is very attenuated and the interest of adding tartrazine to improve the measurement of the signal fades. (ii) Detection of fluorescence spots in the presence of dye It has also been verified that the signal emitted by a fluorophore present as a control in the spots of a microplate is well detected in the presence of a dye. As can be seen in FIG. 11, in the presence of an absorbing solution comprising tartrazine (used at a concentration of 250 μg / ml), the signal detected in fluorescence makes it possible to very clearly define the position of the spots with respect to the substance. of Wells. The addition of the absorbent solution does not prevent the detection of the signal emitted in fluorescence by a fluorophore present in the spots as a control.

权利要求:
Claims (10)
[0001]
REVENDICATIONS1. An analysis method for improving the detection of a signal corresponding to the presence of an analyte comprising the following steps: a) providing a solid support comprising at least one compartment, said compartment comprising at least one spot intended for detection of an analyte, b) placing a sample to be analyzed in the presence of the spot or spots of said compartment, c) placing at least one spot of said compartment at least one analyte detection ligand, said detection ligand of a analyte being coupled to a direct or indirect detection marker, d) when said detection marker is an indirect marker, bringing into presence of said spot or spots of said compartment a reporter of the indirect detection marker coupled to said detection ligand, e) when the reporter used in step d) is coupled to an indirect marker, bringing into the presence of said spot or spots of said compartment a reporter of the coupled indirect detection marker said reporter, f) putting at least one dye in the presence of the spot or spots of said compartment, said one or more dyes being included in a liquid phase in contact with the spot or spots of said compartment, and g) detecting a signal corresponding to the presence of an analyte at the spot or spots of said compartment, in the presence of the liquid phase comprising said one or more dyes.
[0002]
2. A process according to claim 1, characterized in that the dye is selected from the group consisting of tartrazine, quinoline yellow, naphthol yellow S, curcumin, riboflavin and riboflavin 5 'phosphate.
[0003]
3. Method according to claim 1 or 2, characterized in that the signal is detected in step g) from below the solid support.
[0004]
4. Method according to one of claims 1 to 3, characterized in that the signal detected in step g) is the signal emitted by a luminescent compound and / or the signal emitted by a fluorophore.
[0005]
5. Method according to one of claims 1 to 4, characterized in that the dye is provided in the form of an absorbent composition comprising at least one compound selected from the group consisting of luminol, isoluminol, a derivative luminol or isoluminol, an electron mediator, an oxidant and a solvent, for example water.
[0006]
6. Use of at least one dye for improving the detection of a signal corresponding to the presence of an analyte in a solid support analysis method comprising at least one spot.
[0007]
7. Use according to claim 6, characterized in that the detection of a signal corresponding to the presence of an analyte is carried out in the presence of a liquid phase.
[0008]
8. Use according to claim 6 or 7, characterized in that the signal ratio detected on background noise is increased.
[0009]
9. Use according to one of claims 6 to 8, characterized in that the dye is selected from the group consisting of tartrazine, quinoline yellow, naphthol yellow S, curcumin, riboflavin and riboflavin 5 'phosphate.
[0010]
10. Use according to one of claims 6 to 9, characterized in that the signal corresponding to the presence of an analyte is emitted by a chemiluminescent compound and / or a fluorophore.

类似技术:

---

公开号 | 公开日 | 专利标题

---

EP3129783B1|2021-06-02|Use of absorbent particles for improving signal detection in an analysis method

---

EP3129784B1|2019-12-18|Use of a dye for improving signal detection in a method of analysis

---

JP2010112957A|2010-05-20|Fluorescent nanosilica particle, nanofluorescent material, biochip using same, and assay method of same

---

EP3129782B1|2021-01-06|Control marker for implementing methods of analysis on spots

---

FR2544081A1|1984-10-12|SUBSTRATE FOR IMMUNOFLUORESCENCE ANALYSIS

---

JP2018528424A|2018-09-27|Immunoassay with enhanced sensitivity

---

WO2015150583A1|2015-10-08|Control means for implementing multiplex analysis methods

---

EP2828661B1|2016-03-09|Device for determining at least one analyte capable of being contained in a liquid sample

---

KR20210106417A|2021-08-30|Non-enzymatic light assays

---

JP6516679B2|2019-05-22|Method and apparatus for measuring concentration of test substance

---

JP5660035B2|2015-01-28|Fusion protein-containing assembly, method for producing the same, and assay method using the assembly

---

JP2005283296A|2005-10-13|Optical detection method of specimen, and detection system

---

EP3207371B1|2018-12-12|Composition for enzyme immunoassay using immunofluorescence and uses thereof

---

Yoon2016|Fluorescence

---

EP1478767B1|2006-03-29|In vitro serological method of diagnosing infective endocarditis

---

FR3109818A1|2021-11-05|Method for detecting the presence of a pathogen in a biological fluid

---

WO2020260865A1|2020-12-30|A method for detecting an analyte

---

CN104737002A|2015-06-24|Analysis method and analysis kit for simultaneously detecting or quantitating multiple types of target substrances

同族专利:

---

公开号 | 公开日

---

US20170038377A1|2017-02-09|

---

FR3019899B1|2017-12-22|

---

EP3129784B1|2019-12-18|

---

US10564156B2|2020-02-18|

---

EP3129784A1|2017-02-15|

---

WO2015155248A1|2015-10-15|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

US5082768A|1984-06-15|1992-01-21|Mast Immunosystems, Inc.|Attenuator to suppress extraneous light in luminescent specific-binding assays|

---

US20010006820A1|1997-08-01|2001-07-05|Tom Knapp|Photon reducing agents for fluorescence assays|

---

US20100267071A1|2009-02-27|2010-10-21|Beckman Coulter, Inc.|Solution phase homogeneous assays|

---

AU2003296925A1|2002-11-01|2004-06-07|Leucadia Technologies, Inc.|Displacement sandwich immuno-pcr|

---

US8097421B2|2005-12-29|2012-01-17|Intel Corporation|Method for performing a multiplex immunoassay using label disassociation and an integrated substrate|

---

CA2647953A1|2008-12-29|2010-06-29|Sqi Diagnostics Systems Inc.|Multiplex analyte detection|

---

CN108267581A|2012-08-24|2018-07-10|耶鲁大学|For the systems, devices and methods of high-throughput multi detection|

---

FR3019654B1|2014-04-04|2020-10-30|Bio Rad Innovations|CONTROLS FOR THE IMPLEMENTATION OF MULTIPLEX ANALYSIS METHODS|

---

FR3019901B1|2014-04-09|2020-10-30|Bio Rad Innovations|CONTROL MARKER FOR THE IMPLEMENTATION OF ANALYSIS METHODS ON SPOTS|

---

FR3019900B1|2014-04-09|2017-12-22|Bio-Rad Innovations|USE OF ABSORBENT PARTICLES FOR IMPROVING SIGNAL DETECTION IN A METHOD OF ANALYSIS|FR3019654B1|2014-04-04|2020-10-30|Bio Rad Innovations|CONTROLS FOR THE IMPLEMENTATION OF MULTIPLEX ANALYSIS METHODS|

---

FR3019901B1|2014-04-09|2020-10-30|Bio Rad Innovations|CONTROL MARKER FOR THE IMPLEMENTATION OF ANALYSIS METHODS ON SPOTS|

---

FR3019900B1|2014-04-09|2017-12-22|Bio-Rad Innovations|USE OF ABSORBENT PARTICLES FOR IMPROVING SIGNAL DETECTION IN A METHOD OF ANALYSIS|

---

US10961185B2|2015-10-21|2021-03-30|Fujifilm Wako Pure Chemical Chemical Corporation|Stabilizer and stabilization method|

法律状态:
2015-10-16| EXTE| Extension to a french territory|Extension state: PF |

---

2016-04-25| PLFP| Fee payment|Year of fee payment: 3 |

---

2017-04-26| PLFP| Fee payment|Year of fee payment: 4 |

---

2018-04-26| PLFP| Fee payment|Year of fee payment: 5 |

---

2019-04-24| PLFP| Fee payment|Year of fee payment: 6 |

---

2020-04-29| PLFP| Fee payment|Year of fee payment: 7 |

---

2021-04-27| PLFP| Fee payment|Year of fee payment: 8 |

优先权:

---

申请号 | 申请日 | 专利标题

---

FR1453168A|FR3019899B1|2014-04-09|2014-04-09|USE OF A COLOR TO IMPROVE SIGNAL DETECTION IN A METHOD OF ANALYSIS|FR1453168A| FR3019899B1|2014-04-09|2014-04-09|USE OF A COLOR TO IMPROVE SIGNAL DETECTION IN A METHOD OF ANALYSIS|

---

EP15714824.8A| EP3129784B1|2014-04-09|2015-04-08|Use of a dye for improving signal detection in a method of analysis|

---

US15/302,526| US10564156B2|2014-04-09|2015-04-08|Use of a colorant in order to improve signal detection in an analysis method|

---

PCT/EP2015/057633| WO2015155248A1|2014-04-09|2015-04-08|Use of a colorant in order to improve signal detection in an analysis method|